Organicell Regenerative Medicine, Inc.·4

Dec 30, 4:48 PM ET

Meglin Allen James 4

4 · Organicell Regenerative Medicine, Inc. · Filed Dec 30, 2020

Insider Transaction Report

Form 4
Period: 2020-12-21
Transactions
  • Purchase

    Common Stock

    2020-12-21+1,000,00014,589,180 total
Footnotes (2)
  • [F1]Board approved bonus grant of shares
  • [F2]The closing trading price of the stock on the date of the grant was $0.12 per share.

Documents

1 file
  • 4
    ownership.xmlPrimary